You have 9 free searches left this month | for more free features.

City

Augsburg (1)

Beijing (1)

Berlin (1)

Hannover (1)

Lubben (1)

Ratchathewi (1)

Teupitz (1)

Condition

Dementia (2)

Alzheimer Disease (1)

Anxiety Disorders (1)

Dementia, Vascular (1)

Depression (1)

Dysphagia (1)

Pharmacokinetics (1)

Psychosomatic Disorders (1)

Schizophrenia (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 3 (2)

phase 1 (1)

Sponsor

Hannover Medical School (1)

Janssen-Cilag G.m.b.H (1)

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)

Phramongkutklao College of Medicine and Hospital (1)

Collaborator

Silpakorn University (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (3)

Observational (1)

Nicergoline

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Dysphagia Trial in Ratchathewi (Nicergoline)

Not yet recruiting

Dysphagia

Nicergoline

Ratchathewi, Bangkok, Thailand

Phramongkutklao Hospital

Dec 21, 2022

Pharmacokinetics Trial in Beijing (Nicergoline from China, Nicergoline from Italy)

Completed

Pharmacokinetics

Nicergoline from China
Nicergoline from Italy

Beijing, China

Beijing Hospital

Jan 26, 2021

Dementia, Depression, Schizophrenia Trial in Germany (Phenobarbital, Phenytoin, Carbamazepine)

Terminated

Dementia
+4 more

Phenobarbital
+96 more

Augsburg, Germany
+4 more

Feb 27, 2018

Galantamine Versus Nootropics in Alzheimer's Dementia Under

Completed

Dementia
+2 more

Galantamine
Nootropics (ginkgo biloba, nicergoline, piracetam, or others)

(no location specified)

Jun 17, 2014